CeaproTSXV: CZO

Ceapro receives further investment from AVAC Ltd.

· Issued by Ceapro via CNW
CALGARY, April 26 /CNW/ - Edmonton-based company, Ceapro Inc. (CZO - TSX
Venture) today announced an agreement with AVAC Ltd. for an approved
investment of up to $362,250 in Ceapro's product innovation project for
veterinary therapeutics and personal care active ingredients based on Alberta
cereal grains. The AVAC investment will enable Ceapro to further advance its
commercialization project for this new technology. AVAC has provided previous
investments in other Ceapro projects including beta glucan and other oat
extracts, and is continuing to support the Company's products with this
additional financing to expand Ceapro's product lines through successful
commercialization.
"We are appreciative of AVAC's continued support for new product
ventures," said Dr. Mark Redmond, President and CEO of Ceapro Inc. "AVAC's
financial support has been instrumental in moving our business through the
early stages of development and this new investment enables us to accelerate
our product development for use in cosmetics, personal care, and veterinary
therapeutics."
Mike Leslie, Investment Manager with AVAC, stated, "There are great
things ahead for Ceapro. AVAC is very excited to be able to invest in the
expansion of an Alberta venture with international commercialization
opportunities that support value added agriculture in Alberta. It is a perfect
fit."

About Ceapro Inc.
Ceapro Inc., an innovation-driven biotechnology company, develops and
commercializes organic products for medical, cosmetic, and animal health
industries using proprietary technology and natural, renewable resources.
Based in Edmonton, Alberta, Ceapro is one of Alberta Venture's Fastest Growing
Companies for 2004 and 2005 and is one of Profit Magazine's Next
100 Companies. Ceapro is also the recipient of the ASTech Award for
Outstanding Commercial Achievement for companies with annual sales of less
than $25 million. Ceapro will release its 2004 financial results on or before
April 29, 2005. The Company's annual report, containing Management's
Discussion and Analysis and Audited Financial Statements, will be mailed to
shareholders on or about May 2, 2005. Ceapro's annual and special meeting of
shareholders will be held on Wednesday, June 1, 2005. Ceapro's shares trade on
the TSX Venture Exchange under the symbol CZO. Shares Outstanding: 36,355,950,
Recent Close: $0.30.

About AVAC Ltd.
AVAC Ltd is a not-for-profit company dedicated to unleashing value-added
innovation in Alberta. AVAC supports ideas and projects that add value to
agricultural products and invest through coaching, knowledge, contacts and
financial resources. AVAC's mission is to build the economic viability of
Alberta's agrivalue and renewable resource ventures. Created in 1997, AVAC has
to date committed over $32.9 million to agrivalue initiatives. To learn more
about AVAC, visit www.avacltd.com.

The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or the accuracy of this news release.

This release may contain forward-looking statements. Various factors
could cause actual results to differ materially from those projected in
forward-looking statements. Although the Company believes that the     
forward-looking statements contained herein are reasonable, it can give no
assurance that the Company's expectations are correct. All forward-looking
statements are expressly qualified in their entirety by this cautionary
statement.
%SEDAR: 00010110E

Ceapro on 6ix

Earlier from Ceapro

Later from Ceapro

All Ceapro news releases